129 related articles for article (PubMed ID: 8630940)
1. DNA ploidy analysis of mucinous cystic tumors of the pancreas. Correlation of aneuploidy with malignancy and poor prognosis.
Southern JF; Warshaw AL; Lewandrowski KB
Cancer; 1996 Jan; 77(1):58-62. PubMed ID: 8630940
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
[TBL] [Abstract][Full Text] [Related]
4. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
Hyöty M; Visakorpi T; Kallioniemi OP; Mattila J; Laippala P; Nordback I
Eur J Surg; 1991 Oct; 157(10):595-600. PubMed ID: 1687251
[TBL] [Abstract][Full Text] [Related]
6. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
8. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the survival and the clinicopathological parameters of the patients with tumors in the pancreatic head region.
Berczi C; Bocsi J; Lapis K; Balázs G
Acta Chir Hung; 1999; 38(3-4):235-41. PubMed ID: 10935131
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor DNA content in carcinoma of the hepatic duct confluence.
Sato Y; van Gulik TM; Bosma A; Lygidakis NJ; Koyama K; van der Heyde MN
Surgery; 1994 Apr; 115(4):488-94. PubMed ID: 8165540
[TBL] [Abstract][Full Text] [Related]
15. Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade.
Rugge M; Sonego F; Sessa F; Leandro G; Capella C; Sperti C; Pasquali C; Di Mario F; Pedrazzoli S; Ninfo V
Cancer; 1996 Feb; 77(3):459-66. PubMed ID: 8630952
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
17. p53 protein expression and DNA ploidy in cystic tumors of the pancreas.
Fléjou JF; Boulange B; Bernades P; Belghiti J; Hénin D
Pancreas; 1996 Oct; 13(3):247-52. PubMed ID: 8884845
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
[TBL] [Abstract][Full Text] [Related]
19. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy and S + G2M fraction (proliferative index) as prognostic determinants in human periampullary cancer.
Jorba R; Jaurrieta E; Bernat R; Verdaguer J; Fabregat J; Fernandez-Cruz L
Hepatogastroenterology; 1995; 42(5):740-7. PubMed ID: 8751244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
